Patent cliffs & loss of exclusivity
Iovance Biotherapeutics is a late-stage oncology company with the potential to bring the first novel autologous T cell therapy to the market for solid tumors in patients with significant unmet needs.
| AngelList URL | https://angel.co/company/iovance-biotherapeutics |
|---|---|
| Legal Name | Iovance Biotherapeutics, Inc. |
| Company Operating Status | Active |
| Crunchbase URL | https://www.crunchbase.com/organization/lion-biotechnologies |
| Full Address | 825 Industrial Road, Suite 400 San Carlos, CA 94070 |
| LinkedIn URL | https://www.linkedin.com/company/iovance/about/ |
| Pitchbook URL | https://pitchbook.com/profiles/company/42262-12 |
| Previous Name | FREIGHT MANAGEMENT CORP |
Loss-of-exclusivity dates are derived from the FDA Orange & Purple Books; company detail is from the CliffBio graph. Estimates are projections, not legal advice.